Literature DB >> 12213211

Gene delivery to adult neural stem cells.

Anna Falk1, Niklas Holmström, Marie Carlén, Robert Cassidy, Cecilia Lundberg, Jonas Frisén.   

Abstract

Neural stem cells may present an ideal route for gene therapy as well as offer new possibilities for the replacement of neurons lost to injury or disease. However, it has proved difficult to express ectopic genes in stem cells. We report methods to introduce genes into adult neural stem cells using viral and nonviral vectors in vitro and in vivo. Adenoviral and VSV-G-pseudotyped retroviral vectors are more efficient than plasmid transfection or VSV-G lentiviral transduction in vitro. We further show that adult neural stem cells can be directed to a neuronal fate by ectopic expression of neurogenin 2 in vitro. Plasmids can be delivered in vivo when complexed with linear polyethyleneimine, and gene expression can be targeted specifically to neural stem or progenitor cells by the use of specific promoters. These techniques may be utilized both to study the function of various genes in the differentiation of neural stem cells to specific cell fates and, ultimately, for gene therapy or to generate specific differentiated progeny for cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213211     DOI: 10.1006/excr.2002.5569

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

Review 1.  Gene and cell-based therapy for diabetes mellitus: endocrine gene therapeutics.

Authors:  Takashi Sasaki; Kei Fujimoto; Kyoko Sakai; Masami Nemoto; Nozomu Nakai; Naoko Tajima
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 2.  Strengths and limitations of the neurosphere culture system.

Authors:  Josephine B Jensen; Malin Parmar
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

3.  Stem cell transplantation for auditory nerve replacement.

Authors:  Richard A Altschuler; K Sue O'Shea; Josef M Miller
Journal:  Hear Res       Date:  2008-06-13       Impact factor: 3.208

4.  Gene transfer into primary cultures of fetal neural stem cells by a recombinant adenovirus carrying the gene for green fluorescent protein.

Authors:  Yong Fu; Shen-qing Wang; Ying-peng Liu; Guo-peng Wang; Jian-ting Wang; Shu-sheng Gong
Journal:  J Zhejiang Univ Sci B       Date:  2008-04       Impact factor: 3.066

5.  Overexpression of basic helix-loop-helix transcription factors enhances neuronal differentiation of fetal human neural progenitor cells in various ways.

Authors:  Angéline Serre; Evan Y Snyder; Jacques Mallet; Delphine Buchet
Journal:  Stem Cells Dev       Date:  2011-07-18       Impact factor: 3.272

Review 6.  The human brain and its neural stem cells postmortem: from dead brains to live therapy.

Authors:  Robert E Feldmann; Rainer Mattern
Journal:  Int J Legal Med       Date:  2005-10-07       Impact factor: 2.686

7.  Gene delivery to the spinal cord: comparison between lentiviral, adenoviral, and retroviral vector delivery systems.

Authors:  Ahmed A Abdellatif; Jennifer L Pelt; Richard L Benton; Russell M Howard; Pantelis Tsoulfas; Peipei Ping; Xiao-Ming Xu; Scott R Whittemore
Journal:  J Neurosci Res       Date:  2006-08-15       Impact factor: 4.164

8.  Enhanced selective gene delivery to neural stem cells in vivo by an adeno-associated viral variant.

Authors:  Melissa A Kotterman; Tandis Vazin; David V Schaffer
Journal:  Development       Date:  2015-05-15       Impact factor: 6.868

9.  Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone.

Authors:  Ester J Kwon; Jurate Lasiene; Berit E Jacobson; In-Kyu Park; Philip J Horner; Suzie H Pun
Journal:  Biomaterials       Date:  2009-12-09       Impact factor: 12.479

10.  Downstream targets of GATA3 in the vestibular sensory organs of the inner ear.

Authors:  David M Alvarado; Rose Veile; Judith Speck; Mark Warchol; Michael Lovett
Journal:  Dev Dyn       Date:  2009-12       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.